Peptide compound

• 收藏
• 分享

专利权人:

武田薬品工業株式会社

发明人:

浅見 泰司,新居田 歩

申请号：

JP2018111494

公开号：

JP6570705B2

申请日:

2018.06.12

申请国别(地区):

JP

年份:

2019

代理人:

摘要：

To provide a novel peptide compound having high GLP-1 receptor/GIP receptor co-agonist activity and useful as an agent for the prophylaxis or treatment of obesity and the like.SOLUTION: The present invention provides H-Tyr-Aib-Glu-Gly-Thr-α-MePhe-Thr-Ser-Asp-Tyr-Aib-Lys-Tyr-Leu-Asp-Lys-Gln-Ala-Gln-Ala-Glu-Phe-Val-Lys-Trp-Leu-Leu-Lys-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-Lys-NHor salt thereof.SELECTED DRAWING: None

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/